ChemicalBook > Product Catalog >API >Anesthetic Agents >Skeletal muscle relaxants >Dantrolene

Dantrolene

Dantrolene Suppliers list
Company Name: Chengdu Saint - Kay Biotechnology Co., Ltd.  
Tel: 028-85157043 15882256948
Email: 676046971@qq.com
Company Name: Hefei TNJ Chemical Industry Co.,Ltd.  
Tel: +86-0551-65418684 +86-18949823763
Email: sales@tnjchem.com
Company Name: Dideu Industries Group Limited  
Tel: +86-29-81148696 +86-15129568250
Email: 1022@dideu.com
Company Name: Beijing Boorsen Biotechnology Co., Ltd  
Tel: 400-901-9800 18611424007
Email: cis@bioss.com.cn
Company Name: Auschemicals Pty Ltd  
Tel: +86-13822340013
Email: info@auschemicals.com

Dantrolene manufacturers

  • DANTROLENE USP/EP/BP
  • DANTROLENE USP/EP/BP pictures
  • $1.10
  • 2026-08-20
  • CAS:85008-71-5
  • Min. Order: 1g
  • Purity: 99.9%
  • Supply Ability: 100 Tons Min
Dantrolene Basic information
Product Name:Dantrolene
Synonyms:DANTROLENE FREE BASE (FOR R&D ONLY);Dantrolene free base;DANTROLENE USP/EP/BP;2,4-Imidazolidinedione,1-[[[4-(4-nitrophenyl)-2-furanyl]meth...;Dantrolene
CAS:85008-71-5
MF:C14H10N4O5
MW:314.25
EINECS:
Product Categories:
Mol File:85008-71-5.mol
Dantrolene Structure
Dantrolene Chemical Properties
Melting point >236°C (dec.)
density 1.57±0.1 g/cm3(Predicted)
storage temp. Hygroscopic, Refrigerator, under inert atmosphere
solubility DMSO (Slightly), Methanol (Very Slightly, Sonicated)
form Solid
pkapKa 7.5 (Uncertain)
color Yellow to Dark Yellow
Stability:Hygroscopic
Safety Information
MSDS Information
Dantrolene Usage And Synthesis
DescriptionDantrolene is a drug that causes spastic muscle contraction. Unlike other muscle relaxants, it has a direct effect on the contractile mechanism by interfering in the process of calcium ion release from the sarcoplasmic reticulum. This results in a lack of coordination in the mechanism of excitation––contraction of skeletal muscle, which has a greater effect on fast muscle fibers than on slow muscle fibers.
UsesRelaxant (skeletal muscle).
UsesDantrolene is used for controlling the onset of clinical spasticity resulting from serious clinical cases such as wounds, paralysis, cerebral palsy, and disseminated sclerosis. Synonyms of this drug are dantrium and danlen.
Biological FunctionsThe site of action of dantrolene is believed to be at the sarcoplasmic reticulum in skeletal muscle cells. Dantrolene binds to a calcium channel protein (ryanodine receptor) on the sarcoplasmic reticulum to close the channel and inhibit the release of calcium; the alkaloid ryanodine activates the same receptor to open the channel.
Mechanism of actionDantrolene is believed to act directly on the contractile mechanism of skeletal muscle to decrease the force of contraction in the absence of any demonstrated effects on neural pathways, on the neuromuscular junction, or on the excitable properties of the muscle fiber membranes. Cardiac muscle and smooth muscle are minimally affected by dantrolene, likely because calcium release from sarcoplasmic reticulum of these muscle cell types occurs via a mechanism that differs from skeletal muscle. The muscle relaxant effect of dantrolene on skeletal muscle, however, is not specific, and generalized muscle weakness occurs as a major adverse side effect. Like other hydantoins, dantrolene is a weak base (pKa = 7.5) that can cross the blood-brain barrier; thus, CNS depressant side effects (e.g., sedation) are common. Dantrolene sodium salt is slowly absorbed from the gastrointestinal tract. The mean half-life of the drug in adults is approximately 9 hours after a 100-mg dose. It is slowly metabolized by the liver to give the 5-hydroxy and acetamido (nitro reduction and acetylation) metabolites, as well as unchanged drug, excreted in the urine.
Clinical UseDantrolene is a hydantoin derivative that acts peripherally to reduce spasticity and is indicated for use in spinal cord injury, stroke, cerebral palsy, and multiple sclerosis.
SynthesisDantrolene, 1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidinedione (15.2.2), is synthesized by reacting 4-nitrophenyldiazonium chloride with furfurol, forming 5-(4-nitrophenyl)-2-furancarboxaldehyde (15.2.1), which is reacted further with 1-aminohydantoin, to give the corresponding hydrazone, dantrolene (15.2.2).

Synthesis_85008-71-5

Dantrolene Preparation Products And Raw materials
Tag:Dantrolene(85008-71-5) Related Product Information
Tizanidine Eperisone Memantine Dantrolene sodium pentahydrate Dantrolene sodium 4-(4-Nitrophenyl)morpholine Dantrolene sodium SODIUM DANTROLENE,DANTROLENE NA,DANTROLENE SODIUM SALT Dantrolene-13C3